100 related articles for article (PubMed ID: 6214944)
1. Stability of cancer chemotherapeutic agents in a totally implanted drug delivery system.
Keller JH; Ensminger WD
Am J Hosp Pharm; 1982 Aug; 39(8):1321-3. PubMed ID: 6214944
[TBL] [Abstract][Full Text] [Related]
2. Compatibility of morphine, baclofen, floxuridine and fluorouracil in an implantable medication pump.
Sadjak A; Wintersteiger R
Arzneimittelforschung; 1995 Jan; 45(1):93-8. PubMed ID: 7893279
[TBL] [Abstract][Full Text] [Related]
3. An implantable pump for long-term intravascular drug infusion.
Blackshear PJ; Rohde TD; Dorman FD; Buchwald H
Med Instrum; 1981; 15(4):226-8. PubMed ID: 6457965
[TBL] [Abstract][Full Text] [Related]
4. Totally implanted drug delivery system for hepatic arterial chemotherapy.
Ensminger W; Niederhuber J; Dakhil S; Thrall J; Wheeler R
Cancer Treat Rep; 1981; 65(5-6):393-400. PubMed ID: 6263474
[TBL] [Abstract][Full Text] [Related]
5. Drug stability guidelines for a continuous infusion chemotherapy program.
Vyas HM; Baptista RJ; Mitrano FP; Sesin GP
Hosp Pharm; 1987 Jul; 22(7):685-7. PubMed ID: 10282686
[TBL] [Abstract][Full Text] [Related]
6. [Clinical use of a totally implantable and programmable pump for the infusion of drugs].
Balletto N; Cavallini M; Cortesi E; Decian F; Arnone GB; Civalleri D
Minerva Chir; 1992 May; 47(9):859-65. PubMed ID: 1535696
[TBL] [Abstract][Full Text] [Related]
7. Stability and compatibility of drug mixtures in an implantable infusion system.
Bianchi F; Ginggen A; Tardy Y
Anaesthesia; 2008 Sep; 63(9):972-8. PubMed ID: 18699872
[TBL] [Abstract][Full Text] [Related]
8. Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures.
Cheung YW; Vishnuvajjala BR; Flora KP
Am J Hosp Pharm; 1984 Sep; 41(9):1802-6. PubMed ID: 6496516
[TBL] [Abstract][Full Text] [Related]
9. Drug stability and compatibility in oncology care.
Williams DA
J Infus Chemother; 1996; 6(4):195-202. PubMed ID: 9229315
[TBL] [Abstract][Full Text] [Related]
10. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
11. Stability of admixture containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system.
Classen AM; Wimbish GH; Kupiec TC
J Pain Symptom Manage; 2004 Dec; 28(6):603-11. PubMed ID: 15589086
[TBL] [Abstract][Full Text] [Related]
12. In vitro stability and compatibility of daunorubicin, cytarabine, and etoposide.
Seargeant LE; Kobrinsky NL; Sus CJ; Nazeravich DR
Cancer Treat Rep; 1987 Dec; 71(12):1189-92. PubMed ID: 3690528
[TBL] [Abstract][Full Text] [Related]
13. Intraarterial infusion chemotherapy for head and neck cancer using a totally implantable infusion pump.
Baker SR; Wheeler RH; Ensminger WD; Niederhuber JE
Head Neck Surg; 1981; 4(2):118-24. PubMed ID: 6458583
[TBL] [Abstract][Full Text] [Related]
14. Bibliography: ambulatory infusion therapy.
Attilio RM
Hosp Pharm; 1984 Oct; 19(10):662-3, 666-70, 673. PubMed ID: 10299707
[TBL] [Abstract][Full Text] [Related]
15. Treatment of the patient with cancer using parenteral electronic drug administration.
Shaw HL
Cancer; 1992 Aug; 70(4 Suppl):993-7. PubMed ID: 1638470
[TBL] [Abstract][Full Text] [Related]
16. The implantable infusion pump: a new concept in drug delivery.
Blackshear PJ; Rohde TD; Prosl F; Buchwald H
Med Prog Technol; 1979 Nov; 6(4):149-61. PubMed ID: 160505
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy by ambulatory continuous infusion using a portable pump: a feasibility trial].
Benahmed M; Carde P; Laplanche A; Renaux J; Rouesse J; Spielmann M; Sancho-Garnier H
Bull Cancer; 1985; 72(1):30-6. PubMed ID: 2580579
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.
de Lemos ML; Monfared S; Denyssevych T; Hamata L; Jennings S; Thiessen B; Smith S; Waterhouse D
J Oncol Pharm Pract; 2009 Mar; 15(1):45-52. PubMed ID: 18772215
[TBL] [Abstract][Full Text] [Related]
19. Phase I and pharmacokinetic study of the P-glycoprotein modulator dexniguldipine-HCL.
Nuessler V; Scheulen ME; Oberneder R; Kriegmair M; Goebel KJ; Rathgeb F; Wurst W; Zech K; Wilmanns W
Eur J Med Res; 1997 Feb; 2(2):55-61. PubMed ID: 9085015
[TBL] [Abstract][Full Text] [Related]
20. Physical and chemical stability of pemetrexed in infusion solutions.
Zhang Y; Trissel LA
Ann Pharmacother; 2006 Jun; 40(6):1082-5. PubMed ID: 16720706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
